BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 26762501)

  • 1. Escherichia coli N-Acetylglucosamine-1-Phosphate-Uridyltransferase/Glucosamine-1-Phosphate-Acetyltransferase (GlmU) Inhibitory Activity of Terreic Acid Isolated from Aspergillus terreus.
    Sharma R; Lambu MR; Jamwal U; Rani C; Chib R; Wazir P; Mukherjee D; Chaubey A; Khan IA
    J Biomol Screen; 2016 Apr; 21(4):342-53. PubMed ID: 26762501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of novel small molecule inhibitors of the acetyltransferase activity of Escherichia coli N-acetylglucosamine-1-phosphate-uridyltransferase/glucosamine-1-phosphate-acetyltransferase (GlmU).
    Sharma R; Rani C; Mehra R; Nargotra A; Chib R; Rajput VS; Kumar S; Singh S; Sharma PR; Khan IA
    Appl Microbiol Biotechnol; 2016 Apr; 100(7):3071-85. PubMed ID: 26563552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro validation of acetyltransferase activity of GlmU as an antibacterial target in Haemophilus influenzae.
    Buurman ET; Andrews B; Gao N; Hu J; Keating TA; Lahiri S; Otterbein LR; Patten AD; Stokes SS; Shapiro AB
    J Biol Chem; 2011 Nov; 286(47):40734-42. PubMed ID: 21984832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-throughput screen identifies small molecule inhibitors targeting acetyltransferase activity of Mycobacterium tuberculosis GlmU.
    Rani C; Mehra R; Sharma R; Chib R; Wazir P; Nargotra A; Khan IA
    Tuberculosis (Edinb); 2015 Dec; 95(6):664-677. PubMed ID: 26318557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-throughput screening identifies novel inhibitors of the acetyltransferase activity of Escherichia coli GlmU.
    Pereira MP; Blanchard JE; Murphy C; Roderick SL; Brown ED
    Antimicrob Agents Chemother; 2009 Jun; 53(6):2306-11. PubMed ID: 19349513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PknB-mediated phosphorylation of a novel substrate, N-acetylglucosamine-1-phosphate uridyltransferase, modulates its acetyltransferase activity.
    Parikh A; Verma SK; Khan S; Prakash B; Nandicoori VK
    J Mol Biol; 2009 Feb; 386(2):451-64. PubMed ID: 19121323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression, essentiality, and a microtiter plate assay for mycobacterial GlmU, the bifunctional glucosamine-1-phosphate acetyltransferase and N-acetylglucosamine-1-phosphate uridyltransferase.
    Zhang W; Jones VC; Scherman MS; Mahapatra S; Crick D; Bhamidi S; Xin Y; McNeil MR; Ma Y
    Int J Biochem Cell Biol; 2008; 40(11):2560-71. PubMed ID: 18573680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational design of inhibitors of the bacterial cell wall synthetic enzyme GlmU using virtual screening and lead-hopping.
    Doig P; Boriack-Sjodin PA; Dumas J; Hu J; Itoh K; Johnson K; Kazmirski S; Kinoshita T; Kuroda S; Sato TO; Sugimoto K; Tohyama K; Aoi H; Wakamatsu K; Wang H
    Bioorg Med Chem; 2014 Nov; 22(21):6256-69. PubMed ID: 25262942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of novel cell wall inhibitors of Mycobacterium tuberculosis GlmM and GlmU.
    Li Y; Zhou Y; Ma Y; Li X
    Carbohydr Res; 2011 Sep; 346(13):1714-20. PubMed ID: 21704310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copurification of glucosamine-1-phosphate acetyltransferase and N-acetylglucosamine-1-phosphate uridyltransferase activities of Escherichia coli: characterization of the glmU gene product as a bifunctional enzyme catalyzing two subsequent steps in the pathway for UDP-N-acetylglucosamine synthesis.
    Mengin-Lecreulx D; van Heijenoort J
    J Bacteriol; 1994 Sep; 176(18):5788-95. PubMed ID: 8083170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and optimization of Escherichia coli GlmU inhibitors: an in silico approach with validation thereof.
    Mehra R; Sharma R; Khan IA; Nargotra A
    Eur J Med Chem; 2015 Mar; 92():78-90. PubMed ID: 25544688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substrate-bound crystal structures reveal features unique to Mycobacterium tuberculosis N-acetyl-glucosamine 1-phosphate uridyltransferase and a catalytic mechanism for acetyl transfer.
    Jagtap PK; Soni V; Vithani N; Jhingan GD; Bais VS; Nandicoori VK; Prakash B
    J Biol Chem; 2012 Nov; 287(47):39524-37. PubMed ID: 22969087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of the E. coli bifunctional GlmU acetyltransferase active site with substrates and products.
    Olsen LR; Vetting MW; Roderick SL
    Protein Sci; 2007 Jun; 16(6):1230-5. PubMed ID: 17473010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Inhibitory Effect of GlmU Acetyltransferase Inhibitor TPSA on
    Chen C; Han X; Yan Q; Wang C; Jia L; Taj A; Zhao L; Ma Y
    Front Cell Infect Microbiol; 2019; 9():251. PubMed ID: 31380295
    [No Abstract]   [Full Text] [Related]  

  • 15. Probing the roles of conserved residues in uridyltransferase domain of Escherichia coli K12 GlmU by site-directed mutagenesis.
    Wang S; Fu X; Liu Y; Liu XW; Wang L; Fang J; Wang PG
    Carbohydr Res; 2015 Sep; 413():70-4. PubMed ID: 26101844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of acetyltransferase domain of N-acetylglucosamine-1-phosphate-uridyltransferase/glucosamine-1-phosphate-acetyltransferase (GlmU). Part 1: Hit to lead evaluation of a novel arylsulfonamide series.
    Green OM; McKenzie AR; Shapiro AB; Otterbein L; Ni H; Patten A; Stokes S; Albert R; Kawatkar S; Breed J
    Bioorg Med Chem Lett; 2012 Feb; 22(4):1510-9. PubMed ID: 22297115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential antibacterial properties of the MurA inhibitors terreic acid and fosfomycin.
    Olesen SH; Ingles DJ; Yang Y; Schönbrunn E
    J Basic Microbiol; 2014 Apr; 54(4):322-6. PubMed ID: 23686727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism and Potential Inhibitors of GlmU: A Novel Target for Antimicrobial Drug Discovery.
    Sharma R; Khan IA
    Curr Drug Targets; 2017; 18(14):1587-1597. PubMed ID: 27138757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition studies on Mycobacterium tuberculosis N-acetylglucosamine-1-phosphate uridyltransferase (GlmU).
    Tran AT; Wen D; West NP; Baker EN; Britton WJ; Payne RJ
    Org Biomol Chem; 2013 Dec; 11(46):8113-26. PubMed ID: 24158720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of Production of D-Glucosamine in Escherichia coli by Blocking Three Pathways Involved in the Consumption of GlcN and GlcNAc.
    Li P; Li X; Wen Z; Dong R; Li K; Fan H; Wang R; Wang J; Lv M
    Mol Biotechnol; 2020 Aug; 62(8):387-399. PubMed ID: 32572810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.